S Adachi

Summary

Affiliation: Hyogo College of Medicine
Country: Japan

Publications

  1. ncbi A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya shi, Hyogo 663 8501, Japan
    Oncol Rep 8:285-8. 2001
  2. ncbi Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Hyogo 663, Japan
    Oncol Rep 8:27-31. 2001
  3. ncbi Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan
    Cancer 91:74-9. 2001
  4. ncbi Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Int J Clin Pharmacol Res 21:105-10. 2001
  5. ncbi A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Jpn J Clin Oncol 29:434-7. 1999
  6. ncbi Expression of interleukin-18 and its receptor in mouse ovary
    Y Tsuji
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Am J Reprod Immunol 46:349-57. 2001
  7. ncbi Role of IL-18 in pathogenesis of endometriosis
    H Oku
    Department of Obstetrics and Gynecology, Institute for Advanced Medical Sciences, Japan
    Hum Reprod 19:709-14. 2004
  8. ncbi Malignant epithelial tumor of unknown origin of the broad ligament
    Y Itani
    Department of Obstetrics and Gynecology, Nara Prefectural Nara Hospital, 1 30 1 Hiramatsu cho, Nara shi, Nara, 631 0847, Japan
    Arch Gynecol Obstet 267:113-6. 2002

Collaborators

Detail Information

Publications8

  1. ncbi A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya shi, Hyogo 663 8501, Japan
    Oncol Rep 8:285-8. 2001
    ..This regimen is easy to manage in heavily pretreated patients and seems to have good efficacy. To further assess the efficacy, a phase II study is needed...
  2. ncbi Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Hyogo 663, Japan
    Oncol Rep 8:27-31. 2001
    ..Our results show this to be an effective treatment regimen for epithelial ovarian cancer. Prognosis is good with this combined carboplatin/cisplatin/G-CSF therapy, especially for those patients with microscopic or no residual disease...
  3. ncbi Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan
    Cancer 91:74-9. 2001
    ....
  4. ncbi Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Int J Clin Pharmacol Res 21:105-10. 2001
    ..These results show that this combination chemotherapy effected a high response rate. However, its influence on long-term survival remains to be determined...
  5. ncbi A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma
    S Adachi
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Jpn J Clin Oncol 29:434-7. 1999
    ..The treatment for ovarian clear cell adenocarcinoma has not been established. We planned a pilot study of CPT-11 and cisplatin for the treatment of ovarian clear cell adenocarcinoma...
  6. ncbi Expression of interleukin-18 and its receptor in mouse ovary
    Y Tsuji
    Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan
    Am J Reprod Immunol 46:349-57. 2001
    ..Ovulation is thought to be an inflammation-like reaction in which many pro-inflammatory cytokines are involved. We investigated whether IL-18 is involved in the functions of ovary...
  7. ncbi Role of IL-18 in pathogenesis of endometriosis
    H Oku
    Department of Obstetrics and Gynecology, Institute for Advanced Medical Sciences, Japan
    Hum Reprod 19:709-14. 2004
    ..Interleukin (IL)-18 is a strong pleiotropic cytokine known to be involved in various immune diseases. The aim of this study is to elucidate the role of IL-18 in the pathogenesis of endometriosis...
  8. ncbi Malignant epithelial tumor of unknown origin of the broad ligament
    Y Itani
    Department of Obstetrics and Gynecology, Nara Prefectural Nara Hospital, 1 30 1 Hiramatsu cho, Nara shi, Nara, 631 0847, Japan
    Arch Gynecol Obstet 267:113-6. 2002
    ..After three courses of platinum based adjuvant chemotherapy, the patient is alive with no recurrence at 18 months postoperatively...